BioSpace News Archive

InMed Pharmaceuticals Inc., a leader in the development, manufacturing and commercialization of rare cannabinoids, confirmed that, at its annual general meeting of shareholders held on December 17, 2021, all of the matters put forward before shareholders for consideration and approval as set out in InMed’s notice of meeting and management information circular, dated October 28, 2021, were approved by the shareholders.

Arcturus Therapeutics Holdings Inc. announced that the Compensation Committee of the Company’s Board of Directors and the Company’s Board of Directors approved inducement grants of stock options to purchase an aggregate of 13,800 shares of Arcturus’ common stock to three newly-hired employees.